Comparative Insight into Microglia/Macrophages-Associated Pathways in Glioblastoma and Alzheimer's Disease
J Shi, S Huang - International Journal of Molecular Sciences, 2023 - mdpi.com
Microglia and macrophages are pivotal to the brain's innate immune response and have
garnered considerable attention in the context of glioblastoma (GBM) and Alzheimer's …
garnered considerable attention in the context of glioblastoma (GBM) and Alzheimer's …
[HTML][HTML] Molecular mechanisms of microRNAs in glioblastoma pathogenesis
AB Behrooz, H Latifi-Navid, A Nezhadi, M Świat… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Glioblastoma (GBM) is human's most prevalent and severe brain cancer. Epigenetic
regulators, micro (mi) RNAs, significantly impact cellular health and disease because of their …
regulators, micro (mi) RNAs, significantly impact cellular health and disease because of their …
[HTML][HTML] LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis
J Chu, H Li, Y Xing, J Jia, J Sheng, L Yang… - Biomedicine & …, 2019 - Elsevier
Abstract Background Long non-coding RNAs (lncRNAs) are powerful factors influencing the
tumorigenesis and metastasis of multiple carcinomas. LncRNA MNX1-AS1 plays critical …
tumorigenesis and metastasis of multiple carcinomas. LncRNA MNX1-AS1 plays critical …
Oncolytic viruses as a platform for the treatment of malignant brain tumors
Malignant brain tumors remain incurable diseases. Although much effort has been devoted
to improving patient outcome, multiple factors such as the high tumor heterogeneity, the …
to improving patient outcome, multiple factors such as the high tumor heterogeneity, the …
Clinical benefit and risk of elemene in cancer patients undergoing chemotherapy: a systematic review and meta-analysis
Y Pan, P Wan, L Zhang, C Wang… - Frontiers in Pharmacology, 2023 - frontiersin.org
Introduction: Elemene injection and oral emulsion, known as elemene, have been utilized
have been used in adjuvant therapy for cancer patients in China for more than 20 years. In …
have been used in adjuvant therapy for cancer patients in China for more than 20 years. In …
MicroRNA-Dependent Mechanisms Underlying the Function of a β-Amino Carbonyl Compound in Glioblastoma Cells
Glioblastoma (GB) is an aggressive brain malignancy characterized by its invasive nature.
Current treatment has limited effectiveness, resulting in poor patients' prognoses. β-Amino …
Current treatment has limited effectiveness, resulting in poor patients' prognoses. β-Amino …
SV2B/miR-34a/miR-128 axis as prognostic biomarker in glioblastoma multiforme
D Mustafov, SS Siddiqui, L Klena, E Karteris… - Scientific Reports, 2024 - nature.com
Glioblastoma (GBM) is a heterogenous primary brain tumour that is characterised with
unfavourable patient prognosis. The identification of biomarkers for managing brain …
unfavourable patient prognosis. The identification of biomarkers for managing brain …
Unique interplay between molecular miR-181b/d biomarkers and health related quality of life score in the predictive glioma models
In the last decade, an increasing amount of research has been conducted analyzing
microRNA expression changes in glioma tissue and its expressed exosomes, but there is …
microRNA expression changes in glioma tissue and its expressed exosomes, but there is …
Associations of miR-181a with Health-Related Quality of Life, Cognitive Functioning, and Clinical Data of Patients with Different Grade Glioma Tumors
Gliomas are central nervous system tumors with a lethal prognosis. Small micro-RNA
molecules participate in various biological processes, are tissue-specific, and, therefore …
molecules participate in various biological processes, are tissue-specific, and, therefore …
MicroRNA and mRNA Expression Changes in Glioblastoma Cells Cultivated under Conditions of Neurosphere Formation
MA Dymova, NS Vasileva, EV Kuligina… - Current issues in …, 2022 - mdpi.com
Glioblastoma multiforme (GBM) is one of the most highly metastatic cancers. The study of the
pathogenesis of GBM, as well as the development of targeted oncolytic drugs, require the …
pathogenesis of GBM, as well as the development of targeted oncolytic drugs, require the …